I saw this in thepharmaletter. The India Ministry of Health is calling an emergency meeting of domestic pharmaceutical companies to discuss why there have be an increasing number of India producers selling out to foreign interests as embodied by MNCs.
This comes in the wake of this week's sale of Piramal to Abbott, coupled by fairly recent sales of Ranbaxy to Daiichi Sankyo, Shantha Biotech to Sanofi-Aventis, and Dabur Pharma to Fresenius Kabi. Why?
"The meeting is an attempt by the ministry to find out the reasons behind the trend and to initiate steps, if needed, to overcome the impact of such take-overs, sources told PharmBiz."
Posted by Bruce Lehr May 28th 2010.